Instem PLC
LSE:INS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Instem PLC
Operating Income
Instem PLC
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Instem PLC
LSE:INS
|
Operating Income
£6.5m
|
CAGR 3-Years
32%
|
CAGR 5-Years
51%
|
CAGR 10-Years
20%
|
|
|
Renalytix PLC
LSE:RENX
|
Operating Income
-$16.8m
|
CAGR 3-Years
32%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Operating Income
$30m
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Cambridge Cognition Holdings PLC
LSE:COG
|
Operating Income
-£1.2m
|
CAGR 3-Years
-108%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-7%
|
|
|
Doctor Care Anywhere Group PLC
ASX:DOC
|
Operating Income
£1.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Physitrack PLC
STO:PTRK
|
Operating Income
€508.6k
|
CAGR 3-Years
67%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Instem PLC
Glance View
Instem Plc engages in the provision of information technology solutions and services to the global health and life sciences community. The company is headquartered in Stone, Staffordshire and currently employs 304 full-time employees. The company went IPO on 2010-10-13. The firm operates through four segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trials Acceleration. Its Study Management Solutions is a software that enables organizations to collect, review, manage and report discovery and preclinical report. Its Regulatory Solutions is a software, outsourced services and consultancy for managing, storing, sharing, submitting and maintaining information compliant with agency regulations. The firm's In Silico Solutions enables researchers to generate scientific insights through identification, extraction and analysis of information. Its Clinical Trials Acceleration Solutions is a technology solution and consulting service to facilitate data integration, statistics, analytics and insights for companies any size or stage of clinical trial analysis.
See Also
What is Instem PLC's Operating Income?
Operating Income
6.5m
GBP
Based on the financial report for Dec 31, 2022, Instem PLC's Operating Income amounts to 6.5m GBP.
What is Instem PLC's Operating Income growth rate?
Operating Income CAGR 10Y
20%
Over the last year, the Operating Income growth was 36%. The average annual Operating Income growth rates for Instem PLC have been 32% over the past three years , 51% over the past five years , and 20% over the past ten years .
